Conduit Pharmaceuticals (CDTTW)

Profile

Full Name

Conduit Pharmaceuticals Inc.

Ticker Symbol

CDTTW

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

Indexes

Not included

Website

http://www.conduitpharma.com

Employees

6

Key Details

Price

$0.01

Market cap

-

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.01
CDTTW price is $0.01

30-Day Relative Volume

0.02
CDTTW 30-day relative volume is 0.02

Price Performance

Price Most recent change

-
CDTTW price change on Apr 14, 2025 is unknown

Price YTD change

+110.17%
CDTTW price is up +110.17% since January 1st

Price 1-year change

-84.48%
CDTTW price is down -84.48% year-on-year

Price 3-year change

-
CDTTW price 3-year change is unknown

Price Range

Price All-time high

$0.14
CDTTW price is currently -91.14% below its historical high of $0.14

Price 3-year low

$0.01
CDTTW price is currently +110.17% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

-
CDTTW market capitalization value is unknown

Market cap 3-year change

-
CDTTW market capitalization 3-year change is unknown

Market cap All-time high

-
CDTTW market capitalization all-time high is unknown

Market cap sector rank

-
CDTTW market capitalization is unknown

Shares Outstanding

Shares Outstanding 1-Year Change

-
CDTTW shares outstanding 1-year change is unknown

Shares Outstanding 3-Year Change

-
CDTTW shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-0.60
CDTTW beta is -0.60

200-day SMA

$0.03
CDTTW price is currently -62.42% below its 200-day simple moving average

50-day SMA

$0.01
CDTTW price is currently -5.34% below its 50-day simple moving average

RSI

50.00
CDTTW 14-day relative strength index is 50.00

Volume

0.02
CDTTW 30-day relative volume is 0.02

ATR

$0.00
CDTTW average true range is $0.00

10-day Historical Volatility

610.76%
CDTTW 10-day historical volatility is 610.76%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$0.00
CDTTW annual revenue is $0.00

Revenue Analysts estimate

-
CDTTW annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

0%
CDTTW {parameterFullLabel} has remained unchanged year-on-year

Revenue Sector rank

1.34%
CDTTW annual revenue is higher than 1.34% of companies in Healthcare sector

EPS

EPS

-
CDTTW annual earnings per share value is unknown

EPS Analysts estimate

-
CDTTW annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-
CDTTW annual earnings per share 1-year change is unknown

EPS Sector rank

-
CDTTW annual earnings per share is unknown

Profit

Gross profit

-
CDTTW annual gross profit value is unknown

Gross margin

-
CDTTW annual gross profit margin value is unknown

Operating profit

-$15.12M
CDTTW annual operating income is -$15.12 million

Operating margin

-
CDTTW annual operating profit margin value is unknown

Net income

-$17.80M
CDTTW annual net profit is -$17.80 million

Net margin

-
CDTTW annual net profit margin value is unknown

Expenses

Total expenses

$15.12M
CDTTW annual total expenses is $15.12 million

Operating expenses

$15.12M
CDTTW annual total operating expenses is $15.12 million

Cost of goods sold

-
CDTTW annual cost of goods sold value is unknown

Selling, general & administrative expenses

$12.04M
CDTTW annual SGA is $12.04 million

Depreciation and amortization

$457.00K
CDTTW annual depreciation & amortization is $457.00 thousand

Interest expense

$1.51M
CDTTW annual interest expense is $1.51 million

Income tax

-
CDTTW annual income tax value is unknown

EBIT & EBITDA

EBIT

-$16.31M
CDTTW annual earnings before interest & taxes is -$16.31 million

EBITDA

-$15.35M
CDTTW annual EBITDA is -$15.35 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$4.19M
CDTTW annual total assets is $4.19 million

Non current assets

$1.48M
CDTTW annual long term assets is $1.48 million

Current assets

$2.71M
CDTTW annual total current assets is $2.71 million

Cash and cash equivalents

$554.00K
CDTTW annual cash & cash equivalents is $554.00 thousand

Accounts receivable

-
CDTTW annual accounts receivable value is unknown

Inventory

-
CDTTW annual inventory value is unknown

Liabilities

Total liabilities

$10.99M
CDTTW annual total liabilities is $10.99 million

Long term liabilities

$245.00K
CDTTW annual total long term liabilities is $245.00 thousand

Current liabilities

$10.74M
CDTTW annual total current liabilities is $10.74 million

Accounts payable

$1.43M
CDTTW annual accounts payable is $1.43 million

Debt

Total debt

$7.46M
CDTTW annual total debt is $7.46 million

Total debt 1-year change

+657.06%
CDTTW annual total debt is up +657.06% year-on-year

Long term debt

$107.00K
CDTTW annual long term debt is $107.00 thousand

Short term debt

$7.23M
CDTTW annual short term debt is $7.23 million

Equity & Capital

Shareholders equity

-$6.79M
CDTTW annual stockholders equity is -$6.79 million

Book value

-$6.79M
CDTTW annual book value is -$6.79 million

Retained earnings

-$29.10M
CDTTW annual retained earnings is -$29.10 million

Working capital

-$8.03M
CDTTW annual working capital is -$8.03 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$9.68M
CDTTW annual cash flow from operations is -$9.68 million

Cash from operations 1-year change

-25.33%
CDTTW annual cash flow from operations is down -25.33% year-on-year

Cash from investing

-$43.00K
CDTTW annual cash flow from investing activities is -$43.00 thousand

Cash from investing 1-year change

-105.93%
CDTTW annual cash flow from investing activities is down -105.93% year-on-year

Cash from financing

$6.07M
CDTTW annual cash flow from financing activities is $6.07 million

Cash from financing 1-year change

-44.49%
CDTTW annual cash flow from financing activities is down -44.49% year-on-year

CAPEX

CAPEX

$51.00K
CDTTW annual capital expenditures is $51.00 thousand

CAPEX 1-year change

-
CDTTW annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$9.73M
CDTTW annual free cash flow is -$9.73 million

Free cash flow 1-year change

-25.99%
CDTTW annual free cash flow is down -25.99% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
CDTTW annual gross profit margin value is unknown

Operating margin

-
CDTTW annual operating profit margin value is unknown

Net margin

-
CDTTW annual net profit margin value is unknown

ROA & ROE

ROA

-424.56%
CDTTW annual return on assets is -424.56%

ROE

262.06%
CDTTW annual return on equity is 262.06%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CDTTW price to earnings ratio value is unknown

PE ratio Sector rank

-
CDTTW price to earnings ratio is unknown

PB Ratio

PB ratio

-
CDTTW price to book ratio value is unknown

PB ratio Sector rank

-
CDTTW price to book ratio is unknown

PS Ratio

PS ratio

-
CDTTW price to sales ratio value is unknown

PS ratio Sector rank

-
CDTTW price to sales ratio is unknown

Enterprise value

Enterprise value

-
CDTTW enterprise value value is unknown

Enterprise value Sector rank

-
CDTTW enterprise value is unknown

EV/EBITDA

EV/EBITDA

-
CDTTW EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
CDTTW EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.25
CDTTW annual current ratio is 0.25

Quick ratio

-
CDTTW annual quick ratio value is unknown

Leverage

Debt to equity

-1.10
CDTTW annual debt to equity ratio is -1.10

Interest coverage ratio

-10.83
CDTTW annual interest coverage ratio is -10.83

Risk & Stability

Piotroski F-Score

-
CDTTW piotroski f-score value is unknown

Altman Z-Score

-
CDTTW altman z-score value is unknown

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

  • What is the ticker symbol for Conduit Pharmaceuticals?
  • Does Conduit Pharmaceuticals pay dividends?
  • What sector is Conduit Pharmaceuticals in?
  • What industry is Conduit Pharmaceuticals in?
  • What country is Conduit Pharmaceuticals based in?
  • Is Conduit Pharmaceuticals in the S&P 500?
  • Is Conduit Pharmaceuticals in the NASDAQ 100?
  • Is Conduit Pharmaceuticals in the Dow Jones?
  • When does Conduit Pharmaceuticals report earnings?

What is the ticker symbol for Conduit Pharmaceuticals?

The ticker symbol for Conduit Pharmaceuticals is NASDAQ:CDTTW

Does Conduit Pharmaceuticals pay dividends?

No, Conduit Pharmaceuticals does not pay dividends

What sector is Conduit Pharmaceuticals in?

Conduit Pharmaceuticals is in the Healthcare sector

What industry is Conduit Pharmaceuticals in?

Conduit Pharmaceuticals is in the Biotechnology industry

What country is Conduit Pharmaceuticals based in?

Conduit Pharmaceuticals is headquartered in United States

Is Conduit Pharmaceuticals in the S&P 500?

No, Conduit Pharmaceuticals is not included in the S&P 500 index

Is Conduit Pharmaceuticals in the NASDAQ 100?

No, Conduit Pharmaceuticals is not included in the NASDAQ 100 index

Is Conduit Pharmaceuticals in the Dow Jones?

No, Conduit Pharmaceuticals is not included in the Dow Jones index

When does Conduit Pharmaceuticals report earnings?

The date for Conduit Pharmaceuticals's next earnings report has not been announced yet
On this page